Beranda › Kanker Payudara › Michigan › Saginaw
Uji klinis Kanker Payudara di Saginaw, MI
5 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Saginaw (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- MyMichigan Medical Center Saginaw, Saginaw
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- MyMichigan Medical Center Saginaw, Saginaw
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- MyMichigan Medical Center Saginaw, Saginaw
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- MyMichigan Medical Center Saginaw, Saginaw
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- MyMichigan Medical Center Saginaw, Saginaw
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Saginaw
- Kanker Paru Non-Sel Kecil7 studi
- Kanker Paru6 studi
- Kanker Prostat5 studi
- Kanker Kolorektal4 studi
- Mieloma Multipel3 studi
- Kanker Ovarium3 studi
- Kanker Kolon3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.